Can docetaxel plus estramustine prolong survival of men with metastatic hormone-refractory prostate cancer?

Nat Clin Pract Oncol

Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

Published: February 2005

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc0076DOI Listing

Publication Analysis

Top Keywords

docetaxel estramustine
4
estramustine prolong
4
prolong survival
4
survival men
4
men metastatic
4
metastatic hormone-refractory
4
hormone-refractory prostate
4
prostate cancer?
4
docetaxel
1
prolong
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!